← 홈

ADC

167개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 167개
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD70A (SGN-CD70A)

Renal Cell Carcinoma; Mantle-Cell Lymphoma · Renal Cell Carcinoma

#RenalCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleSutro Biopharma, Inc.Phase 1

STRO-001 (STRO-001)

B-cell Lymphoma; Non Hodgkin Lymphoma · B-cell Lymphoma

#B-cellLymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleGrupo Español de Linfomas y Tra…Phase 2

Soludomerin (Soludomerin)

CLASSICAL HODGKIN LYMPHOMA · CLASSICAL HODGKIN LYMPHOMA

#CLASSICALHODGKINLYMPHOMA#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleTG Therapeutics, Inc.Phase 1

brentuximab vedotin (Adcetris, TGR-1202 + brentuximab vedotin)

Hodgkin's Lymphoma · Hodgkin's Lymphoma

#HodgkinsLymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleTriphase Research and Developme…Phase 1

TRPH-222 (TRPH-222)

Lymphoma; Lymphoma, B-Cell · Lymphoma

#Lymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstalePfizerApproved

inotuzumab ozogamicin-dose level 2 (inotuzumab ozogamicin-dose level 2)

Leukemia; Precursor b-Cell Lymphoblastic Leukemia-Lymphoma · Leukemia

#Leukemia#ADC#Approved#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleNew York Medical CollegePhase 1

pralatraxate, (pralatraxate,)

NK-Cell Lymphoma; NK-Cell Leukemia · NK-Cell Lymphoma

#NK-CellLymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING

9 / 9 페이지

← 이전다음 →